| Description | VDR agonist 2 (compound 16i), a vitamin D receptor (VDR) agonist, effectively inhibits TGF-β1-induced hepatic stellate cell (HSC) activation, demonstrating notable anti-hepatic fibrosis efficacy both in vitro and in vivo [1]. |
| molecular weight | 366.37 |
| Molecular formula | C20H21F3O3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |